News | April 22, 2024
Evotech and Variant Bio partner to develop fibrosis treatment
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
The drug will target specific genetic mutations prevalent in certain types of cancers
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
Subscribe To Our Newsletter & Stay Updated
